Posledná aktualizácia :
19/11/2024
antibiotikum   Ceftaroline fosamil  
Injekcia
Stabilita roztokov Stabilita v zmesiach Faktory ovplyvňujúce stabilitu Kompatibility spôsob podania Odkazy na literatúru PDF
   Chemický vzorec  

Obchodný názov   Obchodný názov     

Obchodné názvy sú orientačné, a zloženie pomocných látok sa môže líšiť v závislosti od krajiny a výrobcu.

Zinforo Argentína, Belgicko, Čile, Francúzsko, Island, Malajzia, Mexiko, Nemecko, Nórsko, Rumunsko, Španielsko, Švajčiarsko, Veľká Británia
Odkazy na literatúru   Injekcia   Odkazy na literatúru : Ceftaroline fosamil  
Typ Publikácia
3249 Časopis Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB.
Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3520 Laboratórium Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3549 Laboratórium Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3643 Laboratórium Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3674 Laboratórium Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3812 Časopis Bhattacharya S, Parekh S, Dedhiya M.
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers.
Int J Pharm Compound 2015 ; 19, 5 : 432-436.
3827 Poster Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828 Poster Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 Poster So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
4055 Časopis Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4059 Časopis Madfai F, Zaidi S, Ming L, Wanandy T, Patel R.
Physical and chemical stability of ceftaroline in an elastomeric infusion device.
EJHP 2017 ; 25, e2
4145 Časopis Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4434 Časopis Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L.
Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
Clin Ther 2019 ; 41, 10: 2162-2170.
4528 Časopis Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4801 Časopis Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J.
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2024 ;51,1:

  Mentions Légales